SC
ARGX icon

Stempoint Capital’s argenx ARGX Stock Holding History

Stempoint Capital’s Portfolio ARGX Stock Details ARGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,484
Closed -$10.1M – 67
2023
Q4 		$10.1M Buy
+26,484
New +$12.3M 2.69% 12

Other funds holding ARGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stempoint Capital's ARGX Position: Q4 2025 in Review

Stempoint Capital sold out of argenx (ARGX) in Q4 2025, closing a stake of 12,465 shares — an estimated $9.19M sold.

Stempoint Capital first reported a position in ARGX in Q3 2025 and held it in 1 quarter. The position peaked at $9.19M in Q3 2025. 507 funds tracked by Wall St. Rank hold ARGX as of Q4 2025.

  • Stempoint Capital reported no remaining argenx position as of Q4 2025 after selling out during the quarter.
  • Stempoint Capital sold 12,465 argenx shares in Q4 2025, an estimated $9.19M.
  • Stempoint Capital first reported a position in argenx in Q3 2025 and held it in 1 quarter.
  • Stempoint Capital's argenx position peaked at $9.19M in Q3 2025.
  • 507 funds tracked by Wall St. Rank held argenx as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.